Table of contents

Clinical and epidemiological research

• Extended report: Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab (15 June, 2016) Free

  Laura C Cappelli, Anna Kristina Gutierrez, Alan N Baer, Jemima Albayda, Rebecca L Manno, Uzma Haque, Evan J Lipson, Karen B Bleich, Ami A Shah, Jarushka Naidoo, Julie R Brahmer, Dung Le, Clifton O Bingham
• Extended report: A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy (6 July, 2015)

  Paul Emery, Jiří Vencovský, Anna Sylwestrzak, Piotr Leszczyński, Wieslawa Porawska, Asta Baranauskaite, Vira Tseluyko, Vyacheslav M Zhdan, Barbara Stasiuk, Roma Milasiene, Aaron Alejandro Barrera Rodriguez, Soo Yeon Cheong, Jeehoon Ghil
• Extended report: A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy (28 August, 2015)

  Jung-Yoon Choe, Nenad Prodanovic, Jaroslaw Niebrzydowski, Ivan Staykov, Eva Dokoupilova, Asta Baranauskaite, Roman Yatsyshyn, Mevludin Mekic, Wieskawa Porawska, Hana Ciferska, Krystyna Jedrychowicz-Rosiak, Agnieszka Zielinska, Jasmine Choi, Young Hee Rho, Josef S Smolen
• Extended report: A phase III, multicentre, randomised, double-blind, active-controlled, parallel-group trial comparing safety and efficacy of HD203, with innovator etanercept, in combination with methotrexate, in patients with rheumatoid arthritis: the HERA study (23 February, 2016)

  Sang-Cheol Bae, Jinseok Kim, Jung-Yoon Choe, Won Park, Sang-Heon Lee, Yong-Beom Park, Seung-Cheol Shim, Shin-Seok Lee, Yoon-Kyoung Sung, Chan-Bum Choi, So-Ra Lee, HanYu Park, Yongho Ahn
• Extended report: Allopurinol and the risk of atrial fibrillation in the elderly: a study using Medicare data (10 May, 2016)

  Jasvinder A Singh, Shaohua Yu
• Extended report: Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1 (23 August, 2016)

  Philip J Mease, Désirée van der Heijde, Christopher T Ritchlin, Masato Okada, Raquel S Cuchacovich, Catherine L Shuler, Chen-Yen Lin, Daniel K Braun, Chin H Lee, Dafna D Gladman
• Extended report: Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study (29 September, 2016)

  Maxime Dougados, Désirée van der Heijde, Ying-Chou Chen, Maria Greenwald, Edit Drescher, Jiajun Liu, Scott Beattie, Sarah Witt, Inmaculada de la Torre, Carol Gaich, Terence Rooney, Douglas Schlichting, Stephanie de Bono, Paul Emery
• Extended report: Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study (10 May, 2016)

  P Emery, C O Bingham, G R Burmester, V P Bykerk, D E Furst, X Mariette, D van der Heijde, R van Vollenhoven, C Arendt, I Mountian, O Purcaru, D Tatla, B VanLunen, M E Weinblatt
• Extended report: Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers (4 May, 2016)

  Karin Hellgren, Lene Dreyer, Elizabeth V Arkema, Bente Glintborg, Lennart T H Jacobsson, Lars-Erik Kristensen, Nils Feltelius, Merete Lund Hetland, Johan Askling
• Extended report: The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor (26 April, 2016)

  S Ajeganova, H W van Steenbergen, M K Verheul, K Forslind, I Hafström, R E M Toes, T W J Huizinga, B Svensson, L A Trouw, A H M van der Helm-van Mil
• Extended report: How well do ACPA discriminate and predict RA in the general population: a study based on 12 590 population-representative Swedish twins (28 April, 2016)

  Aase Haj Hensvold, Thomas Frisell, Patrik K E Magnusson, Rikard Holmdahl, Johan Askling, Anca Irinel Catrina
• Extended report: Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis: a discrete choice experiment among European rheumatologists (17 May, 2016)

  M Hifinger, M Hiligsmann, S Ramiro, V Watson, J L Severens, B Fautrel, T Uhlig, R van Vollenhoven, P Jacques, J Detert, J Canas da Silva, C A Scirè, F Berghea, L Carmona, M Péntek, A Keat, A Boonen
• Extended report: Are allopurinol dose and duration of use nephroprotective in the elderly? A Medicare claims study of allopurinol use and incident renal failure (13 June, 2016)

  Jasvinder A Singh, Shaohua Yu
• Extended report: Does knee replacement surgery for osteoarthritis improve survival? The jury is still out (17 May, 2016)

  Devyani Misra, Na Lu, David Felson, Hyon K Choi, John Seeger, Thomas Einhorn, Tuhina Neogi, Yuqing Zhang
• Extended report: Omega-3 fatty acids are associated with a lower prevalence of autoantibodies in shared epitope-positive subjects at risk for rheumatoid arthritis (17 May, 2016)

  Ryan W Gan, M Kristen Demoruelle, Kevin D Deane, Michael H Weisman, Jane H Buckner, Peter K Gregersen, Ted R Mikuls, James R O'Dell, Richard M Keating, Tasha E Fingerlin, Gary O Zerbe, Michael J Clare-Salzler, V Michael Holers, Jill M Norris
• Extended report:

  Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus

  (9 June, 2016)

  Kendra A Young, Melissa E Munroe, Joel M Guthridge, Diane L Kamen, Timothy B Niewold, Gary S Gilkeson, Michael H Weisman, Mariko L Ishimori, Jennifer Kelly, Patrick M Gaffney, Kathy H Sivils, Rufei Lu, Daniel J Wallace, David R Karp, John B Harley, Judith A James, Jill M Norris
• Extended report: Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study (9 June, 2016)

  Siri Opsahl Hetlevik, Berit Flatø, Marite Rygg, Ellen Berit Nordal, Cathrine Brunborg, Helene Hetland, Vibke Lilleby
• Extended report: Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis (13 June, 2016)

  Claudia Bracaglia, Kathy de Graaf, Denise Pires Marafon, Florence Guilhot, Walter Ferlin, Giusi Prencipe, Ivan Caiello, Sergio Davì, Grant Schulert, Angelo Ravelli, Alexei A Grom, Cristina de Min, Fabrizio De Benedetti
• Extended report: Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study (7 June, 2016)

  Marco Gattorno, Laura Obici, Marco Cattalini, Vincent Tormey, Ken Abrams, Nicole Davis, Antonio Speziale, Suraj G Bhansali, Alberto Martini, Helen J Lachmann
• Extended report: Establishment of reference intervals for osteoarthritis-related soluble biomarkers: the FNIH/OARSI OA Biomarkers Consortium (24 June, 2016)

  Virginia B Kraus, David E Hargrove, David J Hunter, Jordan B Renner, Joanne M Jordan
• Extended report: Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA Biomarkers Consortium (13 June, 2016)

  Virginia Byers Kraus, Jamie E Collins, David Hargrove, Elena Losina, Michael Nevitt, Jeffrey N Katz, Susanne X Wang, Linda J Sandell, Steven C Hoffmann, David J Hunter
• Extended report: Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial (7 June, 2016)

  Jose M Álvaro-Gracia, Juan A Jover, Rosario García-Vicuña, Luis Carreño, Alberto Alonso, Sara Marsal, Francisco Blanco, Victor M Martínez-Taboada, Peter Taylor, Cristina Martín-Martín, Olga DelaRosa, Ignacio Tagarro, Federico Díaz-González
• Concise report: Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: results from a randomised phase III trial (FUTURE 1) (11 May, 2016)

  Vibeke Strand, Philip Mease, Laure Gossec, Ori Elkayam, Filip van den Bosch, James Zuazo, Luminita Pricop, Shephard Mpofu
• Concise report: High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort (31 May, 2016)

  Meghna Jani, John D Isaacs, Ann W Morgan, Anthony G Wilson, Darren Plant, Kimme L Hyrich, Hector Chinoy, Anne Barton
• Concise report: Bone marrow lesions and synovitis on MRI associate with radiographic progression after 2 years in hand osteoarthritis (20 June, 2016)

  W Damman, R Liu, JL Bloem, FR Rosendaal, M Reijnierse, M Kloppenburg